Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andrzej Bargiel (Ostrow Wielkopolski, Poland), Andrzej Bargiel, Andrzej Obojski. Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients. Eur Respir J 2015; 46: Suppl. 59, 3939

Member's Comments

No comment yet.

Related content which might interest you: High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 GOLD recommendations for COPD management Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Implications of under treatment of stable COPD (SAVING study) Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Results of a pulmonary rehabilitation program (PRP) in COPD patients: Differences in outcomes according to currently 2011 GOLD groups Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2 Year: 2014 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations Source: International Congress 2015 – Latest insights into chronic care Year: 2015 The 2013 updated GOLD strategy: A comparison of the various scenarios Source: International Congress 2014 – Best abstracts in chronic care Year: 2014